Lab Interviews

Andrew Browne, MD, PhD, shares how his lab leverages optics, microfluidics, and AI to develop advanced tools for diagnosing and treating eye disease. Grounded in his clinical experience, his work aims to transform how vision care is delivered through cutting-edge technology.

Cherlyn J. Ng, PhD, shares insights into her work on retinal disease. She discusses the innovative approaches her lab is using to better understand and treat vision loss, and how collaboration drives scientific discovery at CTVR.

Grazyna Palczewska, PhD, focuses on developing advanced imaging technologies to visualize the retina with greater precision. Her work supports earlier detection and improved understanding of retinal diseases through innovation in optical imaging and data analysis.

Gulab Zode, PhD, shares how his lab investigates the underlying molecular mechanisms of glaucoma. By focusing on disease pathways and therapeutic targets, his research aims to develop more effective treatments that go beyond symptom management to address the root causes of vision loss.

Krzysztof Palczewski, PhD, discusses his lab’s groundbreaking work on the biochemical pathways of vision and gene-based therapies for inherited retinal disorders. His research aims to restore sight and slow degeneration through innovative molecular and translational approaches.

Magdalene Seiler, PhD, shares her research on developing stem cell-based therapies to replace damaged retinal tissue. Her lab focuses on understanding cell integration and function in the eye, with the goal of restoring vision in patients with degenerative retinal diseases.

Philip Kiser, PharmD, PhD, discusses his lab’s work on the molecular and structural biology of the visual cycle. By studying key enzymes and pathways in the retina, his research aims to uncover therapeutic strategies for retinal diseases linked to dysfunctional visual chemistry.

Rui Chen, PhD, shares his lab’s work on identifying genetic mutations linked to inherited retinal diseases. By combining genomics, bioinformatics, and disease modeling, his research aims to improve diagnosis and enable personalized therapies for patients with vision loss.

Vladimir Kefalov, PhD, discusses his lab’s research on the fundamental mechanisms of vision and photoreceptor function. Using innovative imaging and molecular techniques, his work seeks to better understand visual processes and develop new strategies to treat retinal diseases.